Susan G. Komen Foundation: Lobular Breast Cancer Alliance – Metastatic Invasive Lobular Carcinoma – LOI

Supports research on metastatic invasive lobular carcinoma (mILC) that will unlock new knowledge about lobular breast cancer, advance patient care and/or improve patient outcomes of those impacted by mILC. Research to identify better methods of detection, specific treatments and to eradicate lobular breast disease.
Funding: up to $200,000 per year (combined direct and indirect costs) for up to two years.
https://www.komen.org/breast-cancer-research/grants/opportunities/
www.komen.org/wp-content/uploads/2025-Komen-LBCA-LOI-Announcement-and-Instructions.pdf